Breaking News Instant updates and real-time market news.

2021-01-22 13:12:26 EXEL Exelixis $21.63 / +0.3 (+1.41%) 13:12 01/22/21 01/22 13:12 01/22/21 13:12	Exelixis announces FDA approval of CABOMETYX in combination with OPDIVO Exelixis announced that the U.S. Food and Drug Administration approved CABOMETYX for patients with advanced renal cell carcinoma as a first-line treatment in combination with OPDIVO. RCC is the most common form of kidney cancer, which is among the 10 most frequently diagnosed cancers in the U.S. annually. The approval is based on results from CheckMate -9ER, a phase 3 pivotal trial evaluating the combination of CABOMETYX and OPDIVO compared with sunitinib in previously untreated advanced or metastatic RCC. These results were presented during the European Society of Medical Oncology Virtual Congress 2020 in September. The FDA reviewed the application for CABOMETYX and OPDIVO under the Real-Time Oncology Review pilot program and Fast Track designation. The RTOR pilot program, which allows an applicant to pre-submit components of the application to allow the FDA to review clinical trial data before the complete filing is submitted, aims to explore a more efficient review process to ensure safe and effective treatments are available to patients sooner.	20 Feb 01 Mar
EXEL Exelixis $21.63 / +0.3 (+1.41%) 01/20/21 William Blair Exelixis selloff on competitive concerns an 'overreaction,' says William Blair 12/14/20 William Blair Calithera risk/reward attractive into CANTATA readout, says William Blair 10/26/20 Piper Sandler Exelixis could have successor to Cabometyx with XL092, says Piper Sandler 09/22/20 Morgan Stanley Exelixis price target raised to $29 from $23 at Morgan Stanley

2021-01-22 13:12:26

EXEL

Exelixis

$21.63 / +0.3 (+1.41%)

13:12

01/22/21

01/22

13:12

01/22/21

13:12

Exelixis announces FDA approval of CABOMETYX in combination with OPDIVO

Exelixis announced that the U.S. Food and Drug Administration approved CABOMETYX for patients with advanced renal cell carcinoma as a first-line treatment in combination with OPDIVO. RCC is the most common form of kidney cancer, which is among the 10 most frequently diagnosed cancers in the U.S. annually. The approval is based on results from CheckMate -9ER, a phase 3 pivotal trial evaluating the combination of CABOMETYX and OPDIVO compared with sunitinib in previously untreated advanced or metastatic RCC. These results were presented during the European Society of Medical Oncology Virtual Congress 2020 in September. The FDA reviewed the application for CABOMETYX and OPDIVO under the Real-Time Oncology Review pilot program and Fast Track designation. The RTOR pilot program, which allows an applicant to pre-submit components of the application to allow the FDA to review clinical trial data before the complete filing is submitted, aims to explore a more efficient review process to ensure safe and effective treatments are available to patients sooner.

20
Feb
01
Mar

EXEL Exelixis

$21.63 / +0.3 (+1.41%)

01/20/21 William Blair: Exelixis selloff on competitive concerns an 'overreaction,' says William Blair

12/14/20 William Blair: Calithera risk/reward attractive into CANTATA readout, says William Blair

10/26/20 Piper Sandler: Exelixis could have successor to Cabometyx with XL092, says Piper Sandler

09/22/20 Morgan Stanley: Exelixis price target raised to $29 from $23 at Morgan Stanley

TODAY'S FREE FLY STORIES

Hot Stocks	Torm plc to purchase eight tankers from Team Tankers for $82.5M, 5.97M shares » 05:28 03/01/21 03/01 05:28 03/01/21 05:28 TRMD Torm plc $8.38 / -0.375 (-4.29%) Torm has entered into an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Events TRMD Torm plc $8.38 / -0.375 (-4.29%) 07/09/20 Kepler Cheuvreux Torm plc initiated with a Buy at Kepler Cheuvreux 09:00 Today Torm plc - TRMD
Upgrade	Yandex upgraded to Overweight from Equal Weight at Morgan Stanley » 05:26 03/01/21 03/01 05:26 03/01/21 05:26 YNDX Yandex $63.99 / -0.74 (-1.14%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly YNDX Yandex $63.99 / -0.74 (-1.14%) 10/16/20 Yandex, Tinkoff terminate acquisition discussions 09/22/20 Yandex confirms discussions with Tinkoff Group 09/04/20 Yandex, Uber agree to spin off self-driving vehicles business YNDX Yandex $63.99 / -0.74 (-1.14%) 02/09/21 Renaissance Capital Yandex upgraded to Buy from Hold at Renaissance Capital 12/10/20 Fly Intel: Top five analyst downgrades 12/10/20 HSBC Yandex downgraded to Hold from Buy at HSBC 12/09/20 HSBC Yandex downgraded to Hold from Buy at HSBC YNDX Yandex $63.99 / -0.74 (-1.14%) 02/16/21 Yandex reports Q4 EPS 3c, consensus 15c 10/28/20 Yandex reports Q3 revenue $732.1M, consensus $722.67M 25 Jun YNDX Yandex $63.99 / -0.74 (-1.14%) 11/05/20 Fly Intel: What to watch in Uber earnings report
Upgrade	Spirit AeroSystems upgraded to Overweight from Equal Weight at Morgan Stanley » 05:24 03/01/21 03/01 05:24 03/01/21 05:24 SPR Spirit AeroSystems $42.85 / -0.54 (-1.24%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options SPR Spirit AeroSystems $42.85 / -0.54 (-1.24%) 02/23/21 Spirit AeroSystems announces backlog of approximately $34B at end of Q4 02/08/21 Infosys announces strategic collaboration with Spirit AeroSystems 02/03/21 NASA awards contract to Spirit AeroSystems subsidiary 11/16/20 Paul Singer's Elliott buys Cubic, exits AT&T in Q3 SPR Spirit AeroSystems $42.85 / -0.54 (-1.24%) 02/25/21 Cowen Spirit AeroSystems price target raised to $55 from $46 at Cowen 01/21/21 Fly Intel: Top five analyst upgrades 01/21/21 Credit Suisse Spirit AeroSystems upgraded to Outperform from Neutral at Credit Suisse 01/21/21 Credit Suisse Spirit AeroSystems upgraded to Outperform from Neutral at Credit Suisse SPR Spirit AeroSystems $42.85 / -0.54 (-1.24%) 02/23/21 Spirit AeroSystems reports Q4 adjusted EPS ($1.31), consensus (85c) 02/22/21 Notable companies reporting before tomorrow's open 02/22/21 Notable companies reporting before tomorrow's open 11/03/20 Spirit AeroSystems reports Q3 adjusted EPS ($1.34), consensus ($1.34) SPR Spirit AeroSystems $42.85 / -0.54 (-1.24%) 02/23/21 Fly Intel: Wall Street's top stories for Tuesday 02/23/21 Fly Intel: Wall Street's top stories at midday 02/23/21 Fly Intel: Pre-market Movers 11/18/20 Boeing rises after FAA lifts order grounding 737 MAX SPR Spirit AeroSystems $42.85 / -0.54 (-1.24%) 10/16/20 Spirit AeroSystems call volume above normal and directionally bullish
Hot Stocks	Chevron announces investment in Baseload Capital » 05:23 03/01/21 03/01 05:23 03/01/21 05:23 CVX Chevron $100.01 / -2.33 (-2.28%) Chevron announced an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CVX Chevron $100.01 / -2.33 (-2.28%) 02/16/21 Berkshire Hathaway buys Verizon, exits Barrick Gold in Q4 02/16/21 Buffett's Berkshire reports new 48.5M share stake in Chevron 02/08/21 Noble Midstream receives proposal from Chevron to acquire outstanding units 02/05/21 Chevron offers to buy Noble Midstream Partners for $12.47 per unit CVX Chevron $100.01 / -2.33 (-2.28%) 02/17/21 Credit Suisse Credit Suisse downgrades 'range-bound' Noble Midstream to Neutral 02/16/21 Credit Suisse Chevron price target raised to $115 from $110 at Credit Suisse 02/16/21 Piper Sandler Noble Midstream downgraded to Neutral from Overweight at Piper Sandler 02/01/21 Wells Fargo Chevron price target lowered to $99 from $105 at Wells Fargo CVX Chevron $100.01 / -2.33 (-2.28%) 01/29/21 Chevron reports Q4 adjusted EPS (1c), consensus 7c 01/28/21 Notable companies reporting before tomorrow's open 01/28/21 Notable companies reporting before tomorrow's open 10/30/20 Chevron reports Q3 adj. EPS 11c, consensus (27c) CVX Chevron $100.01 / -2.33 (-2.28%) 02/17/21 Saudis to raise oil output as prices recover, WSJ reports 01/31/21 Exxon, Chevron CEOs discussed merger last year, WSJ reports 01/26/21 Biden's review of federal oil & gas leases seen as industry threat, WSJ says 01/05/21 Saudi Arabia, Russia reach oil compromise, WSJ reports CVX Chevron $100.01 / -2.33 (-2.28%) 02/17/21 Fly Intel: Wall Street's top stories for Wednesday 02/17/21 Fly Intel: Wall Street's top stories at midday 02/17/21 Fly Intel: Pre-market Movers 02/16/21 Fly Intel: Wall Street's top stories for Tuesday 00:00 Today 26th Annual Energy Virtual Summit 03/09/21 Chevron Corporation CVX Chevron $100.01 / -2.33 (-2.28%) 02/17/21 Early notable gainers among liquid option names on February 17th 02/17/21 Unusually active option classes on open February 17th 02/16/21 Unusually active option classes on open February 16th 11/16/20 Chevron call volume above normal and directionally bullish
Initiation	Carnival plc initiated with a Buy at Peel Hunt » 05:23 03/01/21 03/01 05:23 03/01/21 05:23 CUK Carnival plc $22.58 / +0.63 (+2.87%) Peel Hunt initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research CUK Carnival plc $22.58 / +0.63 (+2.87%) 01/06/21 Carnival's Holland America Line extends pause in cruise operations 01/06/21 Carnival's Princess Cruises extends pause of guest cruise vacations 12/18/20 Carnival takes delivery of new ship, Mardi Gras 12/03/20 Carnival cancels select itineraries for specific operations in 2021 CUK Carnival plc $22.58 / +0.63 (+2.87%) 02/12/21 Berenberg Carnival downgraded to Sell from Hold at Berenberg 01/08/21 Morgan Stanley Carnival plc price target raised to 1,000 GBp from 770 GBp at Morgan Stanley 11/30/20 Barclays Carnival plc price target lowered to 1,725 GBp from 2,250 GBp at Barclays 10/06/20 UBS Carnival plc price target lowered to 1,000 GBp from 1,100 GBp at UBS

Initiation	Royal Mail initiated with a Hold at Peel Hunt » 05:23 03/01/21 03/01 05:23 03/01/21 05:23 ROYMY Royal Mail $0.00 / + (+0.00%) Peel Hunt initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ROYMY Royal Mail $0.00 / + (+0.00%) 02/16/21 Berenberg Royal Mail price target raised to 355 GBp from 280 GBp at Berenberg 02/16/21 Citi Royal Mail price target raised to 600 GBp from 550 GBp at Citi 02/16/21 Jefferies Royal Mail upgraded to Hold from Underperform at Jefferies 02/12/21 Barclays Royal Mail price target raised to 400 GBp from 350 GBp at Barclays
Downgrade	TechnipFMC downgraded to Equal Weight from Overweight at Morgan Stanley » 05:22 03/01/21 03/01 05:22 03/01/21 05:22 FTI TechnipFMC $8.23 / -0.275 (-3.24%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options FTI TechnipFMC $8.23 / -0.275 (-3.24%) 02/24/21 TechnipFMC sees FY21 Subsea revenue $5B-$5.4B 02/24/21 TechnipFMC sees inbound orders for 2021 exceeding $4B achieved in 2020 02/22/21 TechnipFMC unit awarded 'substantial' contract by PETRONAS Carigali 02/17/21 TechnipFMC awarded EPCI contract in offshore Egypt FTI TechnipFMC $8.23 / -0.275 (-3.24%) 02/22/21 Barclays TechnipFMC downgraded to Equal Weight from Overweight at Barclays 02/18/21 Fly Intel: Top five analyst downgrades 02/18/21 Kepler Cheuvreux TechnipFMC downgraded to Hold from Buy at Kepler Cheuvreux 02/18/21 UBS TechnipFMC cut to Neutral at UBS on 'fair' valuation FTI TechnipFMC $8.23 / -0.275 (-3.24%) 02/24/21 TechnipFMC reports Q4 EPS 5c ex-charges and credits, consensus 20c 10/21/20 TechnipFMC sees FY20 Subsea revenue $5.3B-$5.6B 10/21/20 TechnipFMC reports Q3 adjusted EPS 16c, consensus 22c FTI TechnipFMC $8.23 / -0.275 (-3.24%) 02/08/21 Technip, Chiyoda consortium poised to win Quatar LNG plant order, Nikkei says FTI TechnipFMC $8.23 / -0.275 (-3.24%) 02/24/21 Fly Intel: After-Hours Movers 10/21/20 Fly Intel: After-Hours Movers FTI TechnipFMC $8.23 / -0.275 (-3.24%) 02/22/21 Largest borrow rate increases among liquid names 02/19/21 Largest borrow rate increases among liquid names 02/18/21 Largest borrow rate increases among liquid names 02/17/21 Largest borrow rate increases among liquid names
Downgrade	Fortum downgraded to Hold from Buy at Nordea » 05:22 03/01/21 03/01 05:22 03/01/21 05:22 FOJCY Fortum $0.00 / + (+0.00%) Nordea analyst Pasi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research FOJCY Fortum $0.00 / + (+0.00%) 02/16/21 Commerzbank Fortum upgraded to Buy from Hold at Commerzbank 02/01/21 Deutsche Bank Fortum price target lowered to EUR 17 from EUR 18 at Deutsche Bank 01/12/21 Barclays Fortum price target raised to EUR 24 from EUR 22 at Barclays 01/12/21 Deutsche Bank Fortum upgraded to Hold from Sell at Deutsche Bank
Initiation	Ocado Group initiated with a Reduce at Kepler Cheuvreux » 05:21 03/01/21 03/01 05:21 03/01/21 05:21 OCDGF Ocado Group $0.00 / + (+0.00%) Kepler Cheuvreux… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research OCDGF Ocado Group $0.00 / + (+0.00%) 09/28/20 Kroger, Ocado announces Customer Fulfillment Center in Romulus, MI OCDGF Ocado Group $0.00 / + (+0.00%) 02/11/21 Berenberg Ocado Group price target raised to 2,925 GBp from 2,900 GBp at Berenberg 01/21/21 Berenberg Ocado Group price target raised to 2,900 GBp from 2,525 GBp at Berenberg 12/16/20 Credit Suisse Ocado Group price target lowered to 1,319 GBp from 1,335 GBp at Credit Suisse 12/15/20 Berenberg Ocado Group price target lowered to 2,525 GBp from 2,530 GBp at Berenberg
Hot Stocks	Royal Caribbean to begin sailing from Israel in May » 05:21 03/01/21 03/01 05:21 03/01/21 05:21 RCL Royal Caribbean $93.43 / +1.82 (+1.99%) Royal Caribbean will… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options RCL Royal Caribbean $93.43 / +1.82 (+1.99%) 02/22/21 Royal Caribbean sees net loss for Q1, FY21 02/22/21 Royal Caribbean sees FY21 CapEx $2.1B 02/22/21 Royal Caribbean: Monthly cash burn rate consistent with previously noted range 02/22/21 Royal Caribbean sees Q1 net interest expense $243M-$247M RCL Royal Caribbean $93.43 / +1.82 (+1.99%) 02/24/21 Credit Suisse Royal Caribbean price target raised to $117 from $76 at Credit Suisse 02/23/21 JPMorgan Royal Caribbean price target raised to $100 from $91 at JPMorgan 02/23/21 Deutsche Bank Royal Caribbean price target raised to $79 from $62 at Deutsche Bank 02/12/21 Berenberg Royal Caribbean downgraded to Sell from Hold at Berenberg RCL Royal Caribbean $93.43 / +1.82 (+1.99%) 02/22/21 Royal Caribbean reports Q4 adjusted EPS ($5.02), consensus ($5.20) 10/29/20 Royal Caribbean sees incurring loss for Q4 and FY20 10/29/20 Royal Caribbean reports Q3 adjusted EPS ($5.62), consensus ($5.12) 10/28/20 Notable companies reporting before tomorrow's open 14 Oct RCL Royal Caribbean $93.43 / +1.82 (+1.99%) 02/12/21 Royal Caribbean to require COVID-19 vaccinations for crew, Travel + Leisure says 12/08/20 Royal Caribbean cruise from Singapore return after suspected COVID case, ST says 11/13/20 Five people aboard SeaDream cruise ship test positive for COVID, CNN reports 09/30/20 White House planning meeting with cruise line CEOs for Friday, CNBC says RCL Royal Caribbean $93.43 / +1.82 (+1.99%) 12/03/20 Fly Intel: After-Hours Movers 11/09/20 Fly Intel: Wall Street's top stories at midday 11/09/20 Pfizer, BioNTech lift market as COVID vaccine shows effectiveness 11/09/20 Fly Intel: Pre-market Movers RCL Royal Caribbean $93.43 / +1.82 (+1.99%) 02/16/21 Royal Caribbean call volume above normal and directionally bullish 02/16/21 Early notable gainers among liquid option names on February 16th 12/31/20 Unusually active option classes on open December 31st 12/30/20 Royal Caribbean call volume above normal and directionally bullish

Downgrade	Pactiv Evergreen downgraded to Sector Perform from Outperform at RBC Capital » 05:20 03/01/21 03/01 05:20 03/01/21 05:20 PTVE Pactiv Evergreen $13.98 / -0.695 (-4.74%) RBC Capital analyst Arun… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options PTVE Pactiv Evergreen $13.98 / -0.695 (-4.74%) 02/16/21 Third Point buys Upstart, exits Caesars in Q4 PTVE Pactiv Evergreen $13.98 / -0.695 (-4.74%) 02/25/21 BofA Pactiv Evergreen downgraded to Neutral from Buy at BofA 02/25/21 BofA Pactiv Evergreen downgraded to Neutral from Buy at BofA 01/20/21 Deutsche Bank Pactiv Evergreen downgraded to Hold from Buy at Deutsche Bank 01/04/21 Baird Baird downgrades Pactive Evergreen following healthy outperformance PTVE Pactiv Evergreen $13.98 / -0.695 (-4.74%) 02/25/21 Pactiv Evergreen reports Q4 EPS 10c vs. ($1.03) last year 17 Sep PTVE Pactiv Evergreen $13.98 / -0.695 (-4.74%) 09/20/20 Opening Day: Snowflake shares double in biggest software IPO ever PTVE Pactiv Evergreen $13.98 / -0.695 (-4.74%) 10/20/20 One new option listing on October 20th
Upgrade	Kering upgraded to Buy from Hold at Jefferies » 05:20 03/01/21 03/01 05:20 03/01/21 05:20 PPRUY Kering $0.00 / + (+0.00%) Jefferies analyst Flavio… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PPRUY Kering $0.00 / + (+0.00%) 02/22/21 Credit Suisse Kering price target lowered to EUR 635 from EUR 675 at Credit Suisse 02/18/21 UBS Kering price target lowered to EUR 568 from EUR 624 at UBS 02/16/21 Morgan Stanley Kering price target raised to EUR 590 from EUR 550 at Morgan Stanley 02/02/21 Berenberg Kering initiated with a Buy at Berenberg
Upgrade	Swatch Group upgraded to Buy from Hold at Stifel » 05:17 03/01/21 03/01 05:17 03/01/21 05:17 SWGAY Swatch Group $0.00 / + (+0.00%) Stifel analyst Rogerio… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SWGAY Swatch Group $0.00 / + (+0.00%) 02/16/21 RBC Capital Swatch Group price target raised to CHF 265 from CHF 250 at RBC Capital 02/05/21 Goldman Sachs Swatch Group upgraded to Buy from Neutral at Goldman Sachs 02/01/21 Morgan Stanley Swatch Group price target raised to CHF 260 from CHF 195 at Morgan Stanley 02/01/21 Credit Suisse Swatch Group price target raised to CHF 300 from CHF 280 at Credit Suisse
Hot Stocks	Accenture acquires Cirrus, terms undisclosed » 05:16 03/01/21 03/01 05:16 03/01/21 05:16 ACN Accenture $251.01 / -2.8 (-1.10%) Accenture (ACN) has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options ACN Accenture $251.01 / -2.8 (-1.10%) 02/24/21 Accenture, Microsoft partner to help accelerate UK transition to low carbon 02/15/21 Accenture acquires independent SAP partner Edenhouse 02/10/21 Accenture and VMware extend relationship with dedicated business group 02/02/21 Accenture reports acquisition of change management consulting firm Future State ACN Accenture $251.01 / -2.8 (-1.10%) 02/02/21 Berenberg Accenture price target raised to $285 from $258 at Berenberg 01/29/21 Morgan Stanley Morgan Stanley upgrades 'underappreciated' Cognizant to Overweight 01/06/21 BofA Accenture upgraded to Neutral from Underperform at BofA 01/06/21 BofA Accenture upgraded to Neutral from Underperform at BofA ACN Accenture $251.01 / -2.8 (-1.10%) 12/17/20 Accenture raises FY21 GAAP EPS view to $8.17-$8.40 from $7.80-$8.10 12/17/20 Accenture sees Q2 revenue $11.55B-$11.95B, consensus $11.35B 12/17/20 Accenture raises FY21 adj. EPS view to $8.02-$8.25, consensus $8.05 12/17/20 Accenture reports Q1 adjusted EPS $2.17, consensus $2.05 ACN Accenture $251.01 / -2.8 (-1.10%) 12/17/20 Fly Intel: Pre-market Movers 09/24/20 Fly Intel: Pre-market Movers 09/23/20 Tesla upgrade, Apple downgrade among today's top calls on Wall Street 03/18/21 Accenture - ACN ACN Accenture $251.01 / -2.8 (-1.10%) 01/20/21 Largest borrow rate increases among liquid names 12/17/20 Early notable gainers among liquid option names on December 17th 09/24/20 Unusually active option classes on open September 24th
Upgrade	Amadeus IT Group upgraded to Neutral from Reduce at Oddo BHF » 05:15 03/01/21 03/01 05:15 03/01/21 05:15 AMADY Amadeus IT Group / + Oddo BHF analyst Nicolas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events AMADY Amadeus IT Group / + 02/26/21 Microsoft, Amadeus IT Group announce strategic partnership 09/01/20 Amadeus IT Group appoints Till Streichert as CFO AMADY Amadeus IT Group / + 05:15 Today Oddo BHF Amadeus IT Group upgraded to Neutral from Reduce at Oddo BHF 01/25/21 Credit Suisse Amadeus IT Group price target raised to EUR 47.73 at Credit Suisse 01/15/21 Deutsche Bank Amadeus IT Group price target raised to EUR 55 from EUR 45 at Deutsche Bank 01/07/21 Barclays Amadeus IT Group downgraded to Underweight from Equal Weight at Barclays 03/02/21 Amadeus IT Group - AMADY

Upgrade	Amadeus IT Group upgraded to Neutral from Reduce at Oddo BHF » 05:15 03/01/21 03/01 05:15 03/01/21 05:15 AMADY Amadeus IT Group $0.00 / + (+0.00%) Oddo BHF analyst Nicolas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events AMADY Amadeus IT Group $0.00 / + (+0.00%) 02/26/21 Microsoft, Amadeus IT Group announce strategic partnership 09/01/20 Amadeus IT Group appoints Till Streichert as CFO AMADY Amadeus IT Group $0.00 / + (+0.00%) 01/25/21 Credit Suisse Amadeus IT Group price target raised to EUR 47.73 at Credit Suisse 01/15/21 Deutsche Bank Amadeus IT Group price target raised to EUR 55 from EUR 45 at Deutsche Bank 01/07/21 Barclays Amadeus IT Group downgraded to Underweight from Equal Weight at Barclays 12/10/20 Morgan Stanley Amadeus IT Group price target raised to EUR 72 from EUR 67 at Morgan Stanley 03/02/21 Amadeus IT Group - AMADY
Upgrade	IAG upgraded to Buy from Hold at Peel Hunt » 05:14 03/01/21 03/01 05:14 03/01/21 05:14 ICAGY IAG $0.00 / + (+0.00%) Peel Hunt analyst Alex… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Periodicals ICAGY IAG $0.00 / + (+0.00%) 02/23/21 BofA BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list 01/27/21 Berenberg IAG price target raised to 190 GBp from 180 GBp at Berenberg 01/22/21 Kepler Cheuvreux IAG downgraded to Reduce from Hold at Kepler Cheuvreux 01/20/21 Barclays IAG price target raised to 175 GBp from 120 GBp at Barclays ICAGY IAG $0.00 / + (+0.00%) 12/07/20 IAG dismisses Ryanair comments on British Airways holding, Reuters says 11/05/20 British Airways to reduce flight schedule in November, Reuters reports
Upgrade	Vifor Pharma upgraded to Neutral from Sell at UBS » 05:13 03/01/21 03/01 05:13 03/01/21 05:13 GNHAF Vifor Pharma $0.00 / + (+0.00%) UBS analyst Laura… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research GNHAF Vifor Pharma $0.00 / + (+0.00%) 11/09/20 Vifor Pharma, Angion sign licensing agreement for ANG-3777 commercialization 10/20/20 Vifor Pharma, Cara Therapeutics enter license agreement for Korsuva Injection GNHAF Vifor Pharma $0.00 / + (+0.00%) 02/10/21 Barclays Vifor Pharma price target lowered to CHF 120 from CHF 140 at Barclays 01/22/21 UBS Vifor Pharma downgraded to Sell from Neutral at UBS 01/22/21 UBS Vifor Pharma downgraded to Sell from Neutral at UBS 01/04/21 JPMorgan Vifor Pharma downgraded to Underweight from Neutral at JPMorgan
Hot Stocks	WiMi Hologram Cloud announces cooperation with Dream Classroom program » 05:13 03/01/21 03/01 05:13 03/01/21 05:13 WIMI WiMi Hologram Cloud $8.25 / -0.45 (-5.17%) WiMi Hologram Cloud… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly Options WIMI WiMi Hologram Cloud $8.25 / -0.45 (-5.17%) 02/19/21 WiMi Hologram Cloud wins bid for second phase of China Mobile project 02/05/21 WiMi Hologram Cloud launches WiMi HoloAR HUD 01/13/21 WiMi Hologram Cloud jumps 29% to $8.10 after obtaining new patent 01/13/21 WiMi Hologram Cloud obtains patent for 3D holographic pulse laser device WIMI WiMi Hologram Cloud $8.25 / -0.45 (-5.17%) 12/30/20 Fly Intel: Top five analyst calls 12/30/20 Benchmark Benchmark starts WiMi Hologram Cloud at Buy with $8 price target 12/30/20 Benchmark WiMi Hologram Cloud initiated with a Buy at Benchmark 07/13/20 Maxim WiMi Hologram downgraded to Hold from Buy at Maxim 01 Apr WIMI WiMi Hologram Cloud $8.25 / -0.45 (-5.17%) 01/13/21 Fly Intel: Wall Street's top stories for Wednesday 01/13/21 Fly Intel: Wall Street's top stories at midday 12/30/20 Fly Intel: Pre-market Movers WIMI WiMi Hologram Cloud $8.25 / -0.45 (-5.17%) 10/28/20 Seven new option listings on October 28th
Downgrade	Li Ning downgraded to Neutral from Buy at ICBC » 05:12 03/01/21 03/01 05:12 03/01/21 05:12 LNNGF Li Ning $0.00 / + (+0.00%) ICBC analyst Nelson Lee… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research LNNGF Li Ning $0.00 / + (+0.00%) 05/01/20 Goldman Sachs Li Ning upgraded to Conviction Buy from Buy at Goldman Sachs

Downgrade	GB Group downgraded to Hold from Buy at Canaccord » 05:12 03/01/21 03/01 05:12 03/01/21 05:12 GBGPF GB Group $0.00 / + (+0.00%) Canaccord analyst Kai… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research GBGPF GB Group $0.00 / + (+0.00%) 02/25/21 Stifel GB Group upgraded to Buy from Hold at Stifel 10/29/20 Panmure Gordon GB Group upgraded to Buy from Hold at Panmure Gordon 10/20/20 Berenberg GB Group upgraded to Buy from Hold at Berenberg 10/12/20 Citi Citi opens 'positive catalyst watch' on GB Group
Upgrade	Plaza Retail upgraded to Buy from Hold at Industrial Alliance » 05:11 03/01/21 03/01 05:11 03/01/21 05:11 PAZRF Plaza Retail $0.00 / + (+0.00%) Industrial Alliance… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PAZRF Plaza Retail $0.00 / + (+0.00%) 11/16/20 BMO Capital Plaza Retail price target raised to C$3.50 from C$3.25 at BMO Capital 08/17/20 RBC Capital Plaza Retail price target raised to C$3.75 from C$3.50 at RBC Capital 05/15/20 RBC Capital Plaza Retail price target lowered to C$3.50 from C$3.75 at RBC Capital 05/11/20 CIBC Plaza Retail price target lowered to C$3.75 from C$4.25 at CIBC
Upgrade	Pembina Pipeline upgraded to Buy from Hold at Industrial Alliance » 05:10 03/01/21 03/01 05:10 03/01/21 05:10 PBA Pembina Pipeline $25.39 / -2.12 (-7.71%) Industrial Alliance… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PBA Pembina Pipeline $25.39 / -2.12 (-7.71%) 02/25/21 Pembina Pipeline announces share repurchase program 01/19/21 Pembina Pipeline announces binding open season 12/14/20 Pembina Pipeline sees FY21 CapEx $730M 12/14/20 Pembina Pipeline sees 2021 adjusted EBITDA $3.2B-$3.4B PBA Pembina Pipeline $25.39 / -2.12 (-7.71%) 02/26/21 BMO Capital Pembina Pipeline price target raised to C$37 from C$35 at BMO Capital 02/26/21 CIBC Pembina Pipeline price target lowered to C$39 from C$40 at CIBC 02/09/21 Scotiabank Pembina Pipeline downgraded to Sector Perform from Outperform at Scotiabank 01/27/21 Credit Suisse Pembina Pipeline price target raised to C$42 from C$40 at Credit Suisse PBA Pembina Pipeline $25.39 / -2.12 (-7.71%) 02/25/21 Pembina Pipeline reports Q4 EPS ($2.28), may not compare to consensus 44c
Hot Stocks	Polaris to debut 2022 electric Ranger utility side-by-side in late December » 05:09 03/01/21 03/01 05:09 03/01/21 05:09 PII Polaris $117.67 / -2.4 (-2.00%) Polaris unveiled plans to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly PII Polaris $117.67 / -2.4 (-2.00%) 02/17/21 Taiga Motors to merge with SPAC Canaccord Genuity Growth II Corp. 01/28/21 Polaris raises quarterly cash dividend to 63c per share 12/22/20 Polaris appoints Michael Speetzen interim CEO 11/18/20 Polaris falls -6.6% PII Polaris $117.67 / -2.4 (-2.00%) 02/17/21 Morgan Stanley Electric powersports activity could boost Polaris' multiple, says Morgan Stanley 01/27/21 Wedbush Polaris price target raised to $134 from $126 at Wedbush 01/27/21 KeyBanc Polaris price target raised to $138 from $120 at KeyBanc 01/27/21 Truist Polaris price target raised to $125 from $110 at Truist PII Polaris $117.67 / -2.4 (-2.00%) 01/26/21 Polaris sees FY21 adjusted EPS $8.45-$8.75, consensus $7.80 01/26/21 Polaris reports Q4 adjusted EPS $3.34, consensus $2.90 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open PII Polaris $117.67 / -2.4 (-2.00%) 01/26/21 Fly Intel: Pre-market Movers 11/17/20 Fly Intel: After-Hours Movers
Hot Stocks	uCloudlink extends enterprise agreement with Chinese social media company » 05:07 03/01/21 03/01 05:07 03/01/21 05:07 UCL uCloudlink $12.15 / +0.1 (+0.83%) uCloudlink announced it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Syndicate UCL uCloudlink $12.15 / +0.1 (+0.83%) 01/25/21 uCloudlink, Vision expand mobile data connectivity partnership 01/19/21 uCloudlink enters strategic agreement with CVITC for smart container solutions 01/13/21 uCloudlink announces progress in U.S., China patent infringement disputes 01/04/21 uCloudlink, China Mobile continue mobile connectivity partnership 10 Jun

Events

Earnings calls, analyst events, roadshows and more

ZLAB
Today at 08:00

Zai Lab - ZLAB Conference Calls
CWEN
Today at 08:00

Clearway Energy - CWEN Conference Calls
ATNX
Today at 08:00

Athenex - ATNX Conference Calls
EVTC
Today at 08:00

Evertec - EVTC Conference Calls
MORF
Today at 08:00

Morphic Holding - MORF Conference Calls
AXSM
Today at 08:00

Axsome Therapeutics - AXSM Conference Calls
PRGO
Today at 08:00

Perrigo - PRGO Conference Calls
CDLX
Today at 08:00

Cardlytics - CDLX Conference Calls
THRM
Today at 08:00

Gentherm - THRM Conference Calls
ACIA
Today at 08:00

Acacia Communications, Inc. Firm Sponsored Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB $32.00-34.00 31M Shares
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Exelixis announces FDA approval of CABOMETYX in combination with OPDIVO

TODAY'S FREE FLY STORIES

Get Full Fly Access